Post #51261 by jerryab on the US Policy board

Halls of Shrewd'm / US Policy ❤

Unthreaded | Threaded | Whole Thread (160)

Post New | Post Reply | Report Post | Recommend It!

No. of Recommendations: 1

Pricing can't, and won't, meaningfully affect medical spending either.

It depends what is being given a price.

Big difference between drugs and personal professional services.

Drugs CAN be priced, and should have reasonable price controls. That is 30+% of US healthcare costs. The US pays far more for the same drugs, and it buys many of the highest volumes--which means the price/dose in the US should be near the lowest cost. Thus, the US govt is not using the tool it uses in many other purchasing decisions--requiring competitive bidding. That would not apply to newly-approved drugs for a set number of years, but that is normal with a new product under a recent patent. The federal govt already requires drug companies to sell to the VA at a "best price" (set by the company, I believe).

Post New | Post Reply | Report Post | Recommend It!

Print the post

Unthreaded | Threaded | Whole Thread (160)

Prev | Next

Announcements

US Policy FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for Shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.